Studies have confirmed that activation of the Nrf2 signaling pathway exhibits significant protective effects in a range of cardiovascular diseases, including myocardial infarction, myocardial ischemia-reperfusion injury, doxorubicin-induced cardiotoxicity, diabetic cardiomyopathy, and heart failure (24, 25). The gene discussed is NFE2L2; the disease is cardiovascular disorder.